Ardent Health Partners (NYSE:ARDT) Now Covered by Analysts at Morgan Stanley

Morgan Stanley initiated coverage on shares of Ardent Health Partners (NYSE:ARDT) in a research note published on Monday morning, MarketBeat.com reports. The firm issued an overweight rating and a $27.00 price objective on the stock.

ARDT has been the topic of several other research reports. SVB Leerink started coverage on shares of Ardent Health Partners in a report on Monday. They issued an outperform rating and a $23.00 price target on the stock. Truist Financial started coverage on shares of Ardent Health Partners in a report on Monday. They issued a buy rating and a $21.00 price target on the stock. JPMorgan Chase & Co. started coverage on shares of Ardent Health Partners in a report on Monday. They issued a neutral rating and a $18.00 price target on the stock. Finally, Mizuho started coverage on shares of Ardent Health Partners in a research report on Monday. They issued an outperform rating and a $20.00 price objective for the company. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of Buy and a consensus price target of $21.70.

Ardent Health Partners Trading Up 0.2 %

Shares of ARDT stock opened at $16.04 on Monday. Ardent Health Partners has a 1-year low of $15.00 and a 1-year high of $18.16.

Ardent Health Partners Company Profile

We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.